Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.
about
Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinomaLiver transplantation for hepatocellular carcinoma beyond the Milan criteria: A reviewHepatocellular carcinoma: Consensus, controversies and future directions. A report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma MeetingHigher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine AminotransferaseSquaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach.The Warsaw Proposal for the Use of Extended Selection Criteria in Liver Transplantation for Hepatocellular Cancer.Alpha fetoprotein antagonises benzyl isothiocyanate inhibition of the malignant behaviors of hepatocellular carcinoma cells.A Multistep, Consensus-Based Approach to Organ Allocation in Liver Transplantation: Toward a "Blended Principle Model".Hepatocellular carcinoma in patients listed for liver transplantation: Current and future allocation policy and management strategies for the individual patient.Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals.Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun.Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular Carcinoma.Limitations of predicting microvascular invasion in patients with hepatocellular cancer prior to liver transplantation.Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches.The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study.Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer.Total tumor volume predicts survival following liver resection in patients with hepatocellular carcinoma.Molecular markers predicting outcome in hepatocellular carcinoma treated by liver transplantation.Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor.Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation.Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria.Milan criteria and its expansions in liver transplantation for hepatocellular carcinomaLiver transplantation for intermediate hepatocellular carcinoma: An adaptive approach.Expanding transplantation of patients with a liver cancer without harming allocation: a priority in the era of scarce donation.Current state and clinical outcome in Turkish patients with hepatocellular carcinoma.Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels.Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directionsHepatocellular carcinomaTransplantation for colorectal metastases: on the edge of a revolutionTransplantation for hepatocellular cancer: pushing to the limits?Microvascular Invasion in HCC: The Molecular Imaging Perspective
P2860
Q26740332-05BF235D-2E30-4008-A2B6-3AE77E77958DQ26750463-AD50785D-4A48-412D-9A67-ADDD4BF5D330Q26828407-4E5CDD18-55FE-4062-9E8B-D03A350E67C4Q36052952-9FB75F07-AE3B-4EDE-9546-DF3DC8911D1EQ37348887-27892E8F-2CCB-47E0-9BD8-C84718AD46FEQ37560333-4D795D09-1A6B-4221-9960-7B57867046E4Q37689017-F4951A45-4A97-4FE1-9075-4B7003CCCD2FQ38566746-052ED1C4-14F6-4F6D-A5E0-1B798035C0AEQ38604896-4AD90303-EF8B-450E-9DC6-DE377EB10CADQ38763789-68E9453F-35C5-44E2-8AD4-B9DA83E5DEC2Q38821374-564EB65A-1BAA-4634-9A1B-8EDE6621EB39Q38979742-F4B99AC0-89F4-46C9-9D0C-BFC5BF3FC0BEQ39037188-ED7C10F6-C6A8-4629-B5D7-3ABDFD30BB62Q39067623-9E26134D-7582-423A-9069-743925DCB2E0Q39766876-FD3CAC90-B542-4438-9619-103FDBEF7D7FQ40127951-AF427719-94B1-4DF6-B90E-68BD1C567382Q40969175-5CCE4291-614A-427A-99DA-703E9A85C140Q41426492-FE938644-1C3E-42B2-8666-8A1457D4DC77Q41578261-3F852BC9-B85F-4BE2-9938-872FAFB82AF8Q41650892-7218C296-D824-4EB8-AED9-34222379525CQ42256347-A907FC7E-3563-45D2-96D2-543045134202Q42333014-34AC41B1-031A-4B57-AD4B-44DEC2872FDEQ42349921-A97AC5A0-2514-47C7-9B63-FA1341346572Q45147250-C87EC10B-750C-4C4D-8310-6584DBFD2FE4Q49334369-322DFD4B-F5A6-4D19-B437-C7CBBA781896Q55293155-CDD68814-2FAC-4893-8D6B-ED29D8F9AF32Q57167305-B8075449-9BB5-49DA-AAA5-71D98A6C3108Q57756376-DA205621-F626-4B81-862D-4941A5C25DE1Q58550746-B4A242D9-703C-4F16-89E9-00D90A043784Q58554770-975369BD-50B4-4A99-A3CB-C2C9BEF32009Q58583425-97B88A00-4750-4D60-9D6C-E726817450EA
P2860
Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Total tumor volume and alpha-f ...... oma: A prospective validation.
@en
type
label
Total tumor volume and alpha-f ...... oma: A prospective validation.
@en
prefLabel
Total tumor volume and alpha-f ...... oma: A prospective validation.
@en
P2093
P356
P1433
P1476
Total tumor volume and alpha-f ...... oma: A prospective validation.
@en
P2093
Christian Toso
Glenda Meeberg
Jean-François Dufour
Norman M Kneteman
Paul Marotta
Pietro Majno
Roberto Hernandez-Alejandro
P304
P356
10.1002/HEP.27787
P407
P577
2015-04-22T00:00:00Z